Delivery Order SPE2DB22D2218-SPE2DB25FR2KB
Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for UBRELVY 100 MG tablets (10-unit dose packaging) with a ceiling value of $1,146.60. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for UBRELVY 100 mg tablets in unit dose packaging (10-count). The contract, valued at $2,948.50 with a firm fixed price structure, is non-set-aside and competitively awarded. The delivery order is due for completion by June 20, 2025, with performance to be fulfilled at the vendor's Conshohocken...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $22,277.22 by the Defense Logistics Agency for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10s. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025. The award was executed on July 30, 2025, and represents a child contract under AmerisourceBergen's larger relationship with DLA as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,244.42 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packages (16 count) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's pharmaceutical supply support to federal military and healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.44 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10-count unit dose packaging) on September 19, 2025, with completion expected by September 22, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,188.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 MG tablets (16 unit dose packages) on September 8, 2025, with a completion date of September 9, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a $7,463.51 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of UBRELVY 100 MG tablets (unit dose, 10-count packages). This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100-count unit dose packages) valued at $32,471.79 under a firm fixed-price contract type. The order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a non-competitive, non-set-aside award to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that...
- The Defense Logistics Agency awarded a delivery order valued at $2,412.22 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 50 mg tablets in unit-dose packaging of 10s. This competitively awarded contract, valued at $9,038.71, carries a firm fixed price and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...